GRI logo

GRI Bio (GRI)

Profile

Full Name

GRI Bio, Inc.

Ticker Symbol

GRI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 10, 2021

Indexes

Not included

Website

http://www.gribio.com

Employees

3

Key Details

Price

$1.91(-8.61%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$55.19(+98.90% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.91
GRI price is $1.91

30-Day Relative Volume

0.12
GRI 30-day relative volume is 0.12

Price Performance

Price Most recent change

-8.61%
GRI price was down -8.61% on May 6, 2025

Price YTD change

-86.43%
GRI price is down -86.43% since January 1st

Price 1-year change

-97.93%
GRI price is down -97.93% year-on-year

Price 3-year change

-100%
GRI price is down -100% over the past 3 years

Price Range

Price All-time high

$480807.59
GRI price is currently -100.00% below its historical high of $480807.59

Price 3-year low

$1.10
GRI price is currently +73.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.00M
GRI market capitalization is $1.00 million

Market cap 3-year change

-
GRI market capitalization 3-year change is unknown

Market cap All-time high

$25.23M
GRI market capitalization is currently -96.02% below its historical high of $25.23 million

Market cap sector rank

3.99%
GRI market capitalization is higher than 3.99% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2972.51%
GRI shares outstanding is up +2972.51% year-on-year

Shares Outstanding 3-Year Change

-
GRI shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
GRI beta is 0.86

200-day SMA

$9.54
GRI price is currently -79.98% below its 200-day simple moving average

50-day SMA

$4.12
GRI price is currently -53.67% below its 50-day simple moving average

RSI

37.67
GRI 14-day relative strength index is 37.67

Volume

0.12
GRI 30-day relative volume is 0.12

ATR

$0.50
GRI average true range is $0.50

10-day Historical Volatility

165.83%
GRI 10-day historical volatility is 165.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
GRI annual revenue value is unknown

Revenue Analysts estimate

-
GRI annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
GRI annual revenue 1-year change is unknown

Revenue Sector rank

-
GRI annual revenue is unknown

EPS

EPS

-$55.19
GRI annual earnings per share is -$55.19

EPS Analysts estimate

-$3.13
GRI annual earnings per share is currently +1666.01% higher than the consensus analysts' forecast

EPS 1-year change

+98.9%
GRI annual earnings per share is up +98.9% year-on-year

EPS Sector rank

3.71%
GRI annual earnings per share is higher than 3.71% of companies in Healthcare sector

Profit

Gross profit

-
GRI annual gross profit value is unknown

Gross margin

-
GRI annual gross profit margin value is unknown

Operating profit

-$8.23M
GRI annual operating income is -$8.23 million

Operating margin

-
GRI annual operating profit margin value is unknown

Net income

-$8.21M
GRI annual net profit is -$8.21 million

Net margin

-
GRI annual net profit margin value is unknown

Expenses

Total expenses

$8.23M
GRI annual total expenses is $8.23 million

Operating expenses

$8.23M
GRI annual total operating expenses is $8.23 million

Cost of goods sold

-
GRI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.47M
GRI annual SGA is $4.47 million

Depreciation and amortization

$4000.00
GRI annual depreciation & amortization is $4000.00

Interest expense

-
GRI annual interest expense value is unknown

Income tax

-
GRI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$8.23M
GRI annual earnings before interest & taxes is -$8.23 million

EBITDA

-$8.23M
GRI annual EBITDA is -$8.23 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.74M
GRI annual total assets is $5.74 million

Non current assets

$124.00K
GRI annual long term assets is $124.00 thousand

Current assets

$5.62M
GRI annual total current assets is $5.62 million

Cash and cash equivalents

$5.03M
GRI annual cash & cash equivalents is $5.03 million

Accounts receivable

-
GRI annual accounts receivable value is unknown

Inventory

-
GRI annual inventory value is unknown

Liabilities

Total liabilities

$1.71M
GRI annual total liabilities is $1.71 million

Long term liabilities

$71.00K
GRI annual total long term liabilities is $71.00 thousand

Current liabilities

$1.64M
GRI annual total current liabilities is $1.64 million

Accounts payable

$897.00K
GRI annual accounts payable is $897.00 thousand

Debt

Total debt

$119.00K
GRI annual total debt is $119.00 thousand

Total debt 1-year change

+750%
GRI annual total debt is up +750% year-on-year

Long term debt

$71.00K
GRI annual long term debt is $71.00 thousand

Short term debt

$48.00K
GRI annual short term debt is $48.00 thousand

Equity & Capital

Shareholders equity

$4.03M
GRI annual stockholders equity is $4.03 million

Book value

$4.03M
GRI annual book value is $4.03 million

Retained earnings

-$39.74M
GRI annual retained earnings is -$39.74 million

Working capital

$3.98M
GRI annual working capital is $3.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.61M
GRI annual cash flow from operations is -$8.61 million

Cash from operations 1-year change

+4.22%
GRI annual cash flow from operations is up +4.22% year-on-year

Cash from investing

$0.00
GRI annual cash flow from investing activities is $0.00

Cash from investing 1-year change

+100%
GRI annual cash flow from investing activities is up +100% year-on-year

Cash from financing

$11.83M
GRI annual cash flow from financing activities is $11.83 million

Cash from financing 1-year change

+9.58%
GRI annual cash flow from financing activities is up +9.58% year-on-year

CAPEX

CAPEX

-
GRI annual capital expenditures value is unknown

CAPEX 1-year change

-
GRI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.61M
GRI annual free cash flow is -$8.61 million

Free cash flow 1-year change

+4.3%
GRI annual free cash flow is up +4.3% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GRI annual gross profit margin value is unknown

Operating margin

-
GRI annual operating profit margin value is unknown

Net margin

-
GRI annual net profit margin value is unknown

ROA & ROE

ROA

-143.00%
GRI annual return on assets is -143.00%

ROE

-203.55%
GRI annual return on equity is -203.55%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GRI price to earnings ratio value is unknown

PE ratio Sector rank

-
GRI price to earnings ratio is unknown

PB Ratio

PB ratio

0.25
GRI price to book ratio is 0.25

PB ratio Sector rank

21.34%
GRI price to book ratio is higher than 21.34% of companies in Healthcare sector

PS Ratio

PS ratio

-
GRI price to sales ratio value is unknown

PS ratio Sector rank

-
GRI price to sales ratio is unknown

Enterprise value

Enterprise value

-$3.91M
GRI enterprise value is -$3.91 million

Enterprise value Sector rank

6.9%
GRI enterprise value is higher than 6.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.47
GRI EV/EBITDA is 0.47

EV/EBITDA Sector rank

72.86%
GRI EV/EBITDA is higher than 72.86% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.43
GRI annual current ratio is 3.43

Quick ratio

-
GRI annual quick ratio value is unknown

Leverage

Debt to equity

0.03
GRI annual debt to equity ratio is 0.03

Interest coverage ratio

-
GRI annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GRI piotroski f-score value is unknown

Altman Z-Score

-
GRI altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 21, 25 Ascendiant Capital
Buy
Apr 14, 25 HC Wainwright & Co.
Buy
Dec 9, 24 HC Wainwright & Co.
Buy
Dec 5, 24 Ascendiant Capital
Buy

Institutional Ownership

Similar stocks

BIOR logo
Biora Therapeutics (BIOR)
BJDX logo
Bluejay Diagnostics (BJDX)
APDN logo
Applied DNA Sciences (APDN)
LGMK logo
LogicMark (LGMK)
TRVN logo
Trevena (TRVN)
NEPT logo
Neptune Wellness Solutions (NEPT)
SYRS logo
Syros Pharmaceuticals (SYRS)
BIOC logo
Biocept (BIOC)
PBLA logo
Panbela Therapeutics (PBLA)
  • What is the ticker symbol for GRI Bio?
  • Does GRI Bio pay dividends?
  • What sector is GRI Bio in?
  • What industry is GRI Bio in?
  • What country is GRI Bio based in?
  • When did GRI Bio go public?
  • Is GRI Bio in the S&P 500?
  • Is GRI Bio in the NASDAQ 100?
  • Is GRI Bio in the Dow Jones?
  • When does GRI Bio report earnings?
  • Should I buy GRI Bio stock now?

What is the ticker symbol for GRI Bio?

The ticker symbol for GRI Bio is NASDAQ:GRI

Does GRI Bio pay dividends?

No, GRI Bio does not pay dividends

What sector is GRI Bio in?

GRI Bio is in the Healthcare sector

What industry is GRI Bio in?

GRI Bio is in the Biotechnology industry

What country is GRI Bio based in?

GRI Bio is headquartered in United States

When did GRI Bio go public?

GRI Bio's initial public offering (IPO) was on February 10, 2021

Is GRI Bio in the S&P 500?

No, GRI Bio is not included in the S&P 500 index

Is GRI Bio in the NASDAQ 100?

No, GRI Bio is not included in the NASDAQ 100 index

Is GRI Bio in the Dow Jones?

No, GRI Bio is not included in the Dow Jones index

When does GRI Bio report earnings?

The date for GRI Bio's next earnings report has not been announced yet

Should I buy GRI Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page